R&D Insight was incoprotated as a research and development company in the biotechnology industry. The company incurred the following costs relating to various intangible assets

$1.$ During the year, the company completed work on research work had cost $$560,000$

$2.$ The company filed a patent related to the research work. Filing cost amounted to $$35,000$

$3.$ Shortly after recoving the patent, it was challenged in court by another biotechnology company. Intelligencia won the case,

protenting its paptent, but incurred legal fees of $$280,000$

$4.$ The company purchased a patent from another biotechnology company for $$970,000.$ Unfortunatly, this patent was also

challenged in court and Intelligencia lost the case, incurring legal fees of $$175,000$

Do you think the above costs should be capatilized to the balance sheet as an intangble asset or expened on the income statement? Why or why not?